Two Sigma Investments’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Two Sigma Investments's ELV Position: Q2 2026 in Review
Two Sigma Investments increased its Elevance Health (ELV) stake by 12,762% in Q2 2026, buying an estimated $59.6M and bringing the position to 162,061 shares worth $62.7M. The position accounts for 0.05% of the portfolio, ranked #463.
Two Sigma Investments first reported a position in ELV in Q4 2013 and has held it in 41 quarters since. The position peaked at $247M in Q2 2023. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Two Sigma Investments held 162,061 shares of Elevance Health worth $62.7M as of Q2 2026.
- Two Sigma Investments bought 160,801 Elevance Health shares in Q2 2026, an estimated $59.6M.
- Elevance Health made up 0.05% of Two Sigma Investments's portfolio in Q2 2026, its #463 holding.
- Two Sigma Investments first reported a position in Elevance Health in Q4 2013 and has held it in 41 quarters since.
- Two Sigma Investments's Elevance Health position peaked at $247M in Q2 2023.
- 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.